Essential oil treatment for mild to moderate COVID-19
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether an essential oil-based preparation is safe and effective for adults with mild to moderate COVID-19. It could be an option if you are not severely ill and are not taking other COVID treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 64 years old.
- You have tested positive for COVID-19 and have mild to moderate symptoms (not severe).
- You are willing to avoid COVID-19 vaccines during the study.
- You are not currently on antiviral therapy for COVID-19.
- You do not have severe kidney, heart, liver, or other major health problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the body's immune system reacted to COVID-19 in people who had either severe or mild cases. The goal is to learn more about a specific part of the immune response (called IFN-I) to better understand the disease.
This trial tests a new drug called B10-FC in two groups: healthy volunteers and people recently diagnosed with mild-to-moderate COVID-19. It aims to check the drug's safety, how the body processes it, and how the immune system responds. The results will help decide if the drug should be studied further.
This trial tests a combination of two traditional Chinese herbal formulas (Yinqiaosan and Maxingganshitang) to see if they can help people with mild to moderate COVID-19 recover faster. It's for adults who have had symptoms for no more than 3 days and have been diagnosed with a specific Chinese medicine pattern.
This trial studies people with mild to moderate COVID-19 symptoms to better understand and help “post-COVID” condition (ongoing effects after infection). You may be eligible if you’re an adult with a recent confirmed COVID-19 test and you agreed to take part.
This study looks at how your immune system responds to COVID-19 or the flu. It may help researchers understand these infections better, whether you are currently sick or healthy.
This trial looks at how well an antiviral works in the body when started early in people with COVID-19 symptoms. You may be able to join if you’re an otherwise healthy adult with confirmed infection and symptoms for less than 4 days.
Hear when a new COVID-19 Respiratory Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.